Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chiari Malformation Type 2”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Large-scale testing (Phase 3)Study completedNCT02361216
What this trial is testing

Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest

Who this might be right for
Actinic Keratosis
LEO Pharma 729
Not applicableStudy completedNCT04105192
What this trial is testing

Effectiveness of a Natural Ingredient on Obesity

Who this might be right for
Overweight and ObesityHigh Blood Pressure
Universidad Católica San Antonio de Murcia 84
Early research (Phase 1)Study completedNCT01761526
What this trial is testing

Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects

Who this might be right for
Healthy
UCB BIOSCIENCES GmbH 50
Large-scale testing (Phase 3)Study completedNCT01737762
What this trial is testing

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2

Who this might be right for
Venous Leg Ulcers
Healthpoint 155
Not applicableStudy completedNCT05754554
What this trial is testing

Clinical Study of the Treatment of Chiari Malformation Combined With Type II Skull Base Depression

Who this might be right for
Atlantoaxial DislocationChiari MalformationBasilar Invagination
Southern Medical University, China 64
Early research (Phase 1)Study completedNCT00292227
What this trial is testing

Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
UCB Pharma 130
Large-scale testing (Phase 3)WithdrawnNCT03024060
What this trial is testing

Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

Who this might be right for
Actinic Keratosis
DUSA Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT01922050
What this trial is testing

Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis

Who this might be right for
Actinic Keratosis
LEO Pharma 320
Not applicableStudy completedNCT03816709
What this trial is testing

Intramuscular Heating Rates of a Chattanooga Intelect XT Therapeutic Ultrasound

Who this might be right for
Ultrasound Therapy; Complications
North Dakota State University 25
Not applicableUnknownNCT03315637
What this trial is testing

Fetal Endoscopic Surgery for Spina Bifida

Who this might be right for
Neural Tube DefectsSpina Bifida, OpenMyelomeningocele+5 more
Hospital Universitari Vall d'Hebron Research Institute 50
Not applicableActive Not RecruitingNCT06816888
What this trial is testing

Impact of Automatic Prompts in Echocardiographic Reports on Referral to Cardiology

Who this might be right for
Mitral Regurgitation (MR)Moderate or Severe Aortic Stenosis (AS) (Mean Pressure Gradient ≥ 20 mm Hg or Aortic Valve Area ≤ 1.5 cm2)
Ottawa Heart Institute Research Corporation 300
Not applicableActive Not RecruitingNCT03090633
What this trial is testing

Fetoscopic Repair of Isolated Fetal Spina Bifida

Who this might be right for
Spina BifidaMyelomeningoceleChiari Malformation Type 2+3 more
Johns Hopkins University 30
Testing effectiveness (Phase 2)Study completedNCT01998984
What this trial is testing

Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis

Who this might be right for
Actinic Keratosis
LEO Pharma 266
Early research (Phase 1)Study completedNCT03575780
What this trial is testing

Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic Keratosis

Who this might be right for
Actinic Keratoses
Athenex, Inc. 18
Post-approval studies (Phase 4)Study completedNCT00116649
What this trial is testing

Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis

Who this might be right for
Keratosis
Graceway Pharmaceuticals, LLC 551
Early research (Phase 1)Study completedNCT00544258
What this trial is testing

Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005

Who this might be right for
Actinic Keratoses
Peplin 8
Testing effectiveness (Phase 2)Study completedNCT01820260
What this trial is testing

Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis

Who this might be right for
Actinic Keratosis
LEO Pharma 395
Early research (Phase 1)Study completedNCT00791856
What this trial is testing

Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch

Who this might be right for
Healthy
Warner Chilcott 110
Testing effectiveness (Phase 2)Study completedNCT02120456
What this trial is testing

Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis

Who this might be right for
Actinic Keratosis
LEO Pharma 224
Early research (Phase 1)Study completedNCT00659893
What this trial is testing

Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2

Who this might be right for
Actinic Keratosis
Peplin 64
Next Page